Menu

Explaining Elephants’ Cancer Resistance

Two studies reveal that the giant mammals have dozens of extra copies of a cancer-preventing gene.

Oct 13, 2015
Jef Akst

WIKIMEDIA, CHRISTOPHER MICHELWith about 100 times as many cells as a human, a 4,800-kilogram African elephant should, in theory, be more prone to accruing mutations that cause one of those cells to grow out of control. But elephants and other large mammals have surprisingly low rates of cancer, despite living for decades. As Joshua Schiffman, a pediatric oncologist at the University of Utah’s Huntsman Cancer Institute in Salt Lake City, and his colleagues found in a paper published last week (October 8) in JAMA, fewer than 5 percent of captive elephants worldwide die from cancer.

“Long-lived animals with lots of cells should all be dropping dead of cancer,” Schiffman told Science. “But they don’t or they’d go extinct.”

To understand why elephants are apparently cancer resistant, Schiffman and his colleagues scoured the genome of an African elephant and found 40 copies of the p53 gene, known to be important in cancer prevention. The Asian elephant genome contains between 30 and 40 copies of p53. Humans harbor only two copies of the gene. But elephant cells were no better at repairing DNA damage than human cells, in vitro experiments revealed. Instead, the researchers suggested that p53 helps elephants kill off precancerous cells before they become problematic.

Another study published last week (October 6) on the preprint server BioRxiv also found dozens of copies of p53 in the elephant genome, as well as in two extinct species of mammoth. Coauthor Vincent Lynch of the University of Chicago speculated that p53 duplicated as elephant ancestors began to grow in size, but noted that this is likely not the only mechanism to explain the lineage’s cancer resistance.

Cancer biologist Mel Greaves of the Institute for Cancer Research in London agreed. “What would happen if elephants smoked and had a bad diet,” he told Nature. “Would they really be protected from cancer? I doubt it.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!